July 22, 2026
Estrigenix
Estrigenix secured $2 million in seed funding to advance its selective estrogen receptor-beta platform for women's health and neurodegenerative diseases.
- Round
- Seed
- Amount raised
- $2M
- Lead investor
- —
- Industry
- Pharmaceutical Manufacturing
- Headquarters
- —
- Employees
- 2-10 employees
- Website
- —
- View profile →
Source: AllSci